D. E. Shaw & Co., Inc. Veracyte, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 86,182 shares of VCYT stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,182

Previous 95,030 9.31%

Holding current value

$3.54 Million

Previous $3.23 Million 5.54%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$31.92 - $44.4 $282,428 - $392,851	-8,848 Reduced 9.31%	86,182 $3.41 Million
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $2 Million - $3.35 Million	95,030 New	95,030 $3.23 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $480,900 - $666,390	22,900 New	22,900 $507,000
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $398,121 - $533,443	17,829 New	17,829 $398,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $1.61 Million - $2.18 Million	78,190 Added 537.5%	92,737 $2.07 Million
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $1.15 Million - $2.25 Million	-75,266 Reduced 83.8%	14,547 $345,000
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $1.49 Million - $2.51 Million	89,813 New	89,813 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $423,624 - $631,387	-11,738 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $5.51 Million - $8.2 Million	-154,805 Reduced 92.95%	11,738 $545,000
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $529,049 - $909,373	-16,061 Reduced 8.8%	166,543 $6.66 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $6.85 Million - $12.5 Million	153,978 Added 537.9%	182,604 $9.82 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $930,058 - $1.77 Million	28,626 New	28,626 $1.4 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $2.87 Million - $3.72 Million	-120,119 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$22.1 - $28.56 $3.76 Million - $4.86 Million	-170,170 Reduced 58.62%	120,119 $3.42 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $1.34 Million - $2.88 Million	111,772 Added 62.61%	290,289 $7.26 Million
Q4 2018 Feb 14, 2019	BUY	$9.15 - $14.85 $1.63 Million - $2.65 Million	178,517 New	178,517 $2.25 Million

Others Institutions Holding VCYT

# of Institutions

336

Shares Held

81.1M

Call Options Held

202K

Put Options Held

18.6K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.94B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account